Mirada will be showcasing a new range of software planning tools at ASTRO 2011 (Booth #1257) that incorporate its fusion technologies to support: dose warping, dose summation, atlas based auto-contouring, deformable fusion of multi-sequence MR, PET and SPECT and single click contour warping to support adaptive re-planning.
Dr. Mark Gooding, senior scientist at Mirada Medical, will present a study and poster on deformable CT-MR registration (#3262) at ASTRO. The study was chosen from a record breaking 2,437 abstracts submitted for review to be presented. ASTRO is the largest gathering of radiation oncology specialists in the world.
The study, titled “Assessing the quality of deformable CT-MR registration for the purpose of multi-modal radiotherapy planning,” examines the performance of Mirada’s multi-modal deformable registration algorithm for the fusion of head and neck, prostate and cervical diagnostic MR scans to CT planning volumes. Performance was assessed by experts in radiation oncology from four independent clinical institutions and quantitative errors were also measured using landmarks. In all cases, deformable registration significantly improved the alignment between MR and planning CT, approximately halving the registration error compared to conventional rigid alignment. The clinical experts’ assessment concluded that the results required minimal intervention prior to use in multi-modal contouring.
About the Author
Simona Nita is the Digital Marketing Manager at Mirada Medical Ltd. Simona has over 10 years of professional experience and a strong academic background in the field of Marketing.
About Mirada Medical
Mirada Medical is an internationally recognised brand in advanced medical imaging. The company develops high value clinical software applications, which are used across diagnostic radiology, nuclear medicine, radiation oncology, tumour board and elsewhere.
The opinions expressed in this blog represent the views of the author and not necessarily those of Mirada Medical Limited.
Recent Comments